{
    "nctId": "NCT01847001",
    "briefTitle": "Study of Propranolol in Newly Diagnosed Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy",
    "officialTitle": "A Study of the Beta-blocker Propranolol Alone and With Chemotherapy in Patients Receiving Neoadjuvant Treatment for Newly Diagnosed Breast Cancer",
    "overallStatus": "COMPLETED",
    "conditions": "Locally Advanced Malignant Neoplasm, Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "PHASE2",
    "allocation": "NA",
    "primaryPurpose": "OTHER",
    "enrollmentCount": 10,
    "primaryOutcomeMeasure": "Mean Adherence to Propranolol",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* English or Spanish speaking women age \u226518\n* Heart Rate \\> 60 bpm\n* Systolic Blood Pressure \\> 100 mm/Hg\n* Deemed eligible to receive neoadjuvant chemotherapy with 12 cycles of weekly taxane therapy (paclitaxel 80mg/m2 or Abraxane 100 mg/m2 if there is a shortage of paclitaxel) followed by 4 cycles of Adriamycin (60mg/m2) and cyclophosphamide (600 mg/m2) given every 2 weeks with growth-factor support.\n* Echocardiogram (ECHO) or multiple-gated acquisition scan (MUGA) with ejection fraction \\> 50%.\n* Patients with hormone receptor +/- and human epidermal growth factor receptor 2 protein (HER2) +/- breast cancer are eligible\n* If a patient has HER2-positive breast cancer, Herceptin and Perjeta will be given along with taxane therapy\n* Any stage invasive breast cancer provided the primary breast tumor size is \u2265 1 cm\n* Agree to participate in research blood collection at 4 different time periods (20 ml = 4 teaspoons)\n* Agree to the evaluation of already collected core biopsy, as well as surgical resection tissue, for predictive biomarkers. The biopsy prior to Taxol #1 is optional.\n\nExclusion Criteria:\n\n* Patients failing to meet the inclusion criteria\n* Corrected QT interval (QTc) prolongation as defined by \\> 470 milliseconds on electrocardiogram (ECG)\n* First-degree Atrioventricular (AV) block on ECG in which P-R interval lengthened \\> 200 milliseconds; Second Degree; or Third Degree\n* On beta-blocker treatment. If discontinued, patients must have been off beta-blockers for at least 3 months.\n* History of asthma, given concern for \u03b2-blockade in this population",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}